Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,849 | 5,445 | -1,126 | 21,637 | 28,795 |
| Income taxes - deferred | N/A | 3,362 | 7,749 | -11,111 | N/A |
| Accounts receivable | -7,000 | N/A | N/A | N/A | N/A |
| Other Working Capital | -6,827 | -2,336 | -4,024 | 4,152 | 3,604 |
| Other Operating Activity | 7,000 | 0 | 0 | 0 | -61 |
| Operating Cash Flow | $-978 | $6,471 | $2,599 | $14,678 | $32,338 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | 151 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $151 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | N/A | -6,632 | -6,632 | -37,562 | -4,417 |
| Other Financing Activity | 0 | 0 | 0 | -6 | -30 |
| Financing Cash Flow | $N/A | $-6,632 | $-6,632 | $-37,568 | $-4,447 |
| Beginning Cash Position | 7,478 | 7,639 | 11,672 | 34,562 | 6,520 |
| End Cash Position | 6,500 | 7,478 | 7,639 | 11,672 | 34,562 |
| Net Cash Flow | $-978 | $-161 | $-4,033 | $-22,890 | $28,042 |
| Free Cash Flow | |||||
| Operating Cash Flow | -978 | 6,471 | 2,599 | 14,678 | 32,338 |
| Free Cash Flow | -978 | 6,471 | 2,599 | 14,678 | 32,338 |